Inhibition of RPS6K reveals context-dependent Akt activity in luminal breast cancer cells.
Aberrant signaling through insulin (Ins) and insulin-like growth factor I (IGF1) receptors contribute to the risk and advancement of many cancer types by activating cell survival cascades. Similarities between these pathways have thus far prevented the development of pharmacological interventions th...
Saved in:
Main Authors: | Cemal Erdem, Adrian V Lee, D Lansing Taylor, Timothy R Lezon |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/5a50932ee04e4320af6e668981cb0eb3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer
by: Jingyi Liu, et al.
Published: (2018) -
Tightly linked Rps12 and Rps13 genes provide broad-spectrum Phytophthora resistance in soybean
by: Dipak K. Sahoo, et al.
Published: (2021) -
The molecular profile of luminal B breast cancer
by: Creighton CJ
Published: (2012) -
MAGI1 inhibits the AMOTL2/p38 stress pathway and prevents luminal breast tumorigenesis
by: Diala Kantar, et al.
Published: (2021) -
FGFR1 Overexpression Induces Cancer Cell Stemness and Enhanced Akt/Erk-ER Signaling to Promote Palbociclib Resistance in Luminal A Breast Cancer Cells
by: Qiong Cheng, et al.
Published: (2021)